EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
所属公司:EXUMA Biotech, Corp. 当前融资轮次:B+轮 成立日期:2015-01-01 所属地:米德兰 简介:EXUMA Biotechnology是一家为亚洲实体肿瘤市场开发CAR-T解决方案的临床阶段生物技术公司,于2016年4月成立,获得了F1 Oncology, Inc.的资本化和独家技术许可。EXUMA Biotechnology的成立旨在最大限度地发挥F1 Oncology在大...
About EXUMA Biotech EXUMA Biotech is a clinical-stage biotechnology company advancing novel cell and gene therapy platforms for treating autoimmune diseases and cancer. The company's innovations aim to reduce the cost and complexity of...
企业简称EXUMA Biotech企业全称EXUMA Biotech 成立时间-融资阶段B+轮 市值/估值-人员规模- 一级行业医疗健康企业网址https://exumabio.com/ 运营状态运营中公司类型实体企业 一句话简介美国临床生物技术研发商 企业介绍EXUMA Biotech是美国一家临床生物技术研发商,发现和开发针对癌症患者的新型细胞疗法和基因递送解决方...
EXUMA Biotech Corp., a clinical-stage biotechnology company discovering and developing CAR-T products and delivery solutions for liquid and solid tumors, today announced that preclinical data for the company's next-generation rapid point-of-care, or "rPO
EXUMA Biotech, Corp. announced that pre-clinical data from its solid-tumor subcutaneous CAR therapy program will be presented at the virtual 2022 Cancer Immunology and Immunotherapy Conference: Discovery to Mainstream Oncology hosted by the...
5/22,近日,埃秀马生物科技(EXUMA Biotechnology)及其子公司上海普珩生物技术有限公司(Shanghai PerHum Therapeutics)今天发布两款人体首剂实体瘤CAR-T产品用于复发或难治IV期转移性肾细胞癌(mRCC)受试者的中期...
另外,能否跳过或简化淋巴细胞提取过程,本质上就是在应用CAR-T之前,先清除现有的T细胞,为CAR-T细胞在体内的扩张和生长 "腾出空间"?这并不是一个优化的体验,因为它经常会产生后期细胞因子风暴之外的挑战,这也是一个大问题。所以,从长远来看,细胞治疗项目将面临巨大的挑战,这也正是EXUMA Biotech正在做的事情。
EXUMA Biotech, Corp. announced that its Chief Business Officer and Head of Finance, Dr. Gregory Wade, will provide a corporate presentation at 11:25 AM ET on Wednesday, September 14, 2022, as part of the annual Baird Global Healthcare Conference in New Y
EXUMA Biotech, Corp. announced that pre-clinical data from its solid-tumor subcutaneous CAR therapy program will be presented at the virtual 2022 Cancer Immunology and Immunotherapy Conference: Discovery to Mainstream Oncology hosted by the...